AVTX
Price
$4.88
Change
-$0.07 (-1.41%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
52.08M
FGEN
Price
$0.33
Change
+$0.02 (+6.45%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
32.29M
17 days until earnings call
Ad is loading...

AVTX vs FGEN

Header iconAVTX vs FGEN Comparison
Open Charts AVTX vs FGENBanner chart's image
Avalo Therapeutics
Price$4.88
Change-$0.07 (-1.41%)
Volume$400
Capitalization52.08M
FibroGen
Price$0.33
Change+$0.02 (+6.45%)
Volume$10.45K
Capitalization32.29M
AVTX vs FGEN Comparison Chart
Loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTX vs. FGEN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTX is a Hold and FGEN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AVTX: $4.88 vs. FGEN: $0.31)
Brand notoriety: AVTX and FGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTX: 48% vs. FGEN: 12%
Market capitalization -- AVTX: $52.08M vs. FGEN: $30.23M
AVTX [@Biotechnology] is valued at $52.08M. FGEN’s [@Biotechnology] market capitalization is $30.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTX’s FA Score shows that 0 FA rating(s) are green whileFGEN’s FA Score has 0 green FA rating(s).

  • AVTX’s FA Score: 0 green, 5 red.
  • FGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, FGEN is a better buy in the long-term than AVTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTX’s TA Score shows that 4 TA indicator(s) are bullish while FGEN’s TA Score has 4 bullish TA indicator(s).

  • AVTX’s TA Score: 4 bullish, 6 bearish.
  • FGEN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, FGEN is a better buy in the short-term than AVTX.

Price Growth

AVTX (@Biotechnology) experienced а +10.66% price change this week, while FGEN (@Biotechnology) price change was +10.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

AVTX is expected to report earnings on Mar 20, 2025.

FGEN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTX($52.1M) has a higher market cap than FGEN($32.3M). AVTX YTD gains are higher at: -34.320 vs. FGEN (-41.889). AVTX has higher annual earnings (EBITDA): -35.84M vs. FGEN (-101.15M). FGEN has more cash in the bank: 131M vs. AVTX (81.9M). AVTX has less debt than FGEN: AVTX (550K) vs FGEN (79.3M). FGEN has higher revenues than AVTX: FGEN (180M) vs AVTX (820K).
AVTXFGENAVTX / FGEN
Capitalization52.1M32.3M161%
EBITDA-35.84M-101.15M35%
Gain YTD-34.320-41.88982%
P/E Ratio0.09N/A-
Revenue820K180M0%
Total Cash81.9M131M63%
Total Debt550K79.3M1%
FUNDAMENTALS RATINGS
AVTX vs FGEN: Fundamental Ratings
AVTX
FGEN
OUTLOOK RATING
1..100
686
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
9485
P/E GROWTH RATING
1..100
8743
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTX's Valuation (84) in the Pharmaceuticals Other industry is in the same range as FGEN (94) in the Biotechnology industry. This means that AVTX’s stock grew similarly to FGEN’s over the last 12 months.

AVTX's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as FGEN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to FGEN’s over the last 12 months.

AVTX's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as FGEN (100) in the Biotechnology industry. This means that AVTX’s stock grew similarly to FGEN’s over the last 12 months.

FGEN's Price Growth Rating (85) in the Biotechnology industry is in the same range as AVTX (94) in the Pharmaceuticals Other industry. This means that FGEN’s stock grew similarly to AVTX’s over the last 12 months.

FGEN's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for AVTX (87) in the Pharmaceuticals Other industry. This means that FGEN’s stock grew somewhat faster than AVTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTXFGEN
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
AVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KKR113.256.44
+6.03%
KKR & Co
RMTI1.190.04
+3.48%
Rockwell Medical
BPOP95.941.15
+1.21%
Popular
GOGL7.740.09
+1.18%
Golden Ocean Group Limited
RRBI51.480.17
+0.33%
Red River Bancshares

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+2.70%
AVTX - FGEN
57%
Loosely correlated
+1.64%
AXON - FGEN
43%
Loosely correlated
+3.82%
BMRN - FGEN
41%
Loosely correlated
+0.72%
INSM - FGEN
39%
Loosely correlated
-0.70%
CMRX - FGEN
35%
Loosely correlated
N/A
More